Adage Capital Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Adage Capital Partners’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-550,000	Closed	-$95M	–	804
2015 Q1	$95M	Buy	+550,000	New	+$80.7M	0.23%	126
2014 Q3	–	Sell	-600,000	Closed	-$74M	–	786
2014 Q2	$74M	Buy	600,000 +400,000	+200%	+$44.2M	0.19%	150
2014 Q1	$20.7M	Sell	200,000 -50,000	-20%	-$5.12M	0.06%	376
2013 Q4	$22.5M	Buy	250,000 +150,000	+150%	+$12M	0.06%	374
2013 Q3	$6.69M	Sell	100,000 -350,000	-78%	-$24.1M	0.02%	553
2013 Q2	$29.8M	Buy	+450,000	New	+$25.7M	0.09%	276

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Adage Capital Partners's SLXP Position: Q2 2015 in Review

Adage Capital Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 550,000 shares — an estimated $95M sold.

Adage Capital Partners first reported a position in SLXP in Q2 2013 and held it in 6 quarters. The position peaked at $95M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Adage Capital Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Adage Capital Partners sold 550,000 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $95M.
Adage Capital Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 6 quarters.
Adage Capital Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $95M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Adage Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.